Introduction: Cancer cachexia is a multifactorial syndrome characterized by skeletal muscle loss. Cross-sectional analysis of CT scans is a recognized research method for assessing skeletal muscle volume. However, little is known about the relationship between CT-derived estimates of muscle radio-density (SMD) and muscle protein content. We assessed the relationship between CT-derived body composition variables and the protein content of muscle biopsies from cancer patients. Methods: Rectus abdominis biopsies from cancer patients (n = 32) were analysed for protein content and correlated with phenotypic data gathered using CT body composition software. Results: Skeletal muscle protein content varied widely between patients (median...
Background: Muscle mass and physical function (PF) are common co-primary endpoints in cancer cachexi...
Background: Muscle mass and physical function (PF) are common co-primary endpoints in cancer cachexi...
Background: Muscle mass and physical function (PF) are common co-primary endpoints in cancer cachexi...
Introduction: Cancer cachexia is a multifactorial syndrome characterized by skeletal muscle loss....
Background: Progressive loss of muscle mass is a major characteristic of cancer cachexia. Consensus ...
Aim – To relate muscle phenotype to a range of current diagnostic criteria for cancer cachexia M...
Cancer cachexia contributes to poor prognosis through progressive deple-tion of the body’s energy an...
Purpose: Skeletal muscle wasting and weight loss are characteristic features of cancer cachexia and ...
Background: Cachexia affects the majority of patients with advanced cancer and is associated with a ...
Cachexia is a significant clinical problem associated with very poor quality of life, reduced treatm...
Cachexia is a significant clinical problem associated with very poor quality of life, reduced treatm...
Cachexia is a significant clinical problem associated with very poor quality of life, reduced treatm...
Cachexia is a significant clinical problem associated with very poor quality of life, reduced treatm...
Abstract Background There were controversies for the association between computed tomography (CT)‐de...
International audienceResearch investigators have shown a growing interest in investigating alterati...
Background: Muscle mass and physical function (PF) are common co-primary endpoints in cancer cachexi...
Background: Muscle mass and physical function (PF) are common co-primary endpoints in cancer cachexi...
Background: Muscle mass and physical function (PF) are common co-primary endpoints in cancer cachexi...
Introduction: Cancer cachexia is a multifactorial syndrome characterized by skeletal muscle loss....
Background: Progressive loss of muscle mass is a major characteristic of cancer cachexia. Consensus ...
Aim – To relate muscle phenotype to a range of current diagnostic criteria for cancer cachexia M...
Cancer cachexia contributes to poor prognosis through progressive deple-tion of the body’s energy an...
Purpose: Skeletal muscle wasting and weight loss are characteristic features of cancer cachexia and ...
Background: Cachexia affects the majority of patients with advanced cancer and is associated with a ...
Cachexia is a significant clinical problem associated with very poor quality of life, reduced treatm...
Cachexia is a significant clinical problem associated with very poor quality of life, reduced treatm...
Cachexia is a significant clinical problem associated with very poor quality of life, reduced treatm...
Cachexia is a significant clinical problem associated with very poor quality of life, reduced treatm...
Abstract Background There were controversies for the association between computed tomography (CT)‐de...
International audienceResearch investigators have shown a growing interest in investigating alterati...
Background: Muscle mass and physical function (PF) are common co-primary endpoints in cancer cachexi...
Background: Muscle mass and physical function (PF) are common co-primary endpoints in cancer cachexi...
Background: Muscle mass and physical function (PF) are common co-primary endpoints in cancer cachexi...